Beckman Coulter's Q3 Revenues Climb 13.4 Percent | GenomeWeb

NEW YORK (GenomeWeb News) – Beckman Coulter reported after the close of the market on Tuesday that its third-quarter revenues rose 13.4 percent, while its profits slipped on charges.

The firm brought in revenues of $758.8 million for the three months ended Sept. 30, up from $669 million for the third quarter of 2007. Its clinical diagnostics sales increased 13.7 percent to $635.9 million from $559.1 million, and its life sciences sales rose 11.9 percent to $122.9 million from $109.9 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.

Arizona is planning to sue Theranos for "deceptive acts" and misrepresentations of its "capabilities and operation."

If confirmed as Department of Health and Human Services Secretary, Tom Price says he will divest himself of certain holdings, according to Stat News.

Oliver Smithies, who won the Nobel Prize in 2007, has died, the New York Times reports.